Open Access

Local therapy in glioma: An evolving paradigm from history to horizons (Review)

  • Authors:
    • Tamara Ius
    • Teresa Somma
    • Francesco Pasqualetti
    • Jacopo Berardinelli
    • Francesca Vitulli
    • Mario Caccese
    • Eugenia Cella
    • Carlo Cenciarelli
    • Giacomo Pozzoli
    • Giuseppe Sconocchia
    • Marco Zeppieri
    • Caruso Gerardo
    • Maria Caffo
    • Giuseppe Lombardi
  • View Affiliations

  • Published online on: July 17, 2024     https://doi.org/10.3892/ol.2024.14573
  • Article Number: 440
  • Copyright: © Ius et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Despite the implementation of multimodal treatments after surgery, glioblastoma (GBM) remains an incurable disease, posing a significant challenge in neuro‑oncology. In this clinical setting, local therapy (LT), a developing paradigm, has received significant interest over time due to its potential to overcome the drawbacks of conventional therapy options for GBM. The present review aimed to trace the historical development, highlight contemporary advances and provide insights into the future horizons of LT in GBM management. In compliance with the Preferred Reporting Items for Systematic Review and Meta‑Analysis Protocols criteria, a systematic review of the literature on the role of LT in GBM management was conducted. A total of 2,467 potentially relevant articles were found and, after removal of duplicates, 2,007 studies were screened by title and abstract (Cohen's κ coefficient=0.92). Overall, it emerged that 15, 10 and 6 clinical studies explored the clinical efficiency of intraoperative local treatment modalities, local radiotherapy and local immunotherapy, respectively. GBM recurrences occur within 2 cm of the radiation field in 80% of cases, emphasizing the significant influence of local factors on recurrence. This highlights the urgent requirement for LT strategies. In total, three primary reasons have thus led to the development of numerous LT solutions in recent decades: i) Intratumoral implants allow the blood‑brain barrier to be bypassed, resulting in limited systemic toxicity; ii) LT facilitates bridging therapy between surgery and standard treatments; and iii) given the complexity of GBM, targeting multiple components of the tumor microenvironment through ligands specific to various elements could have a synergistic effect in treatments. Considering the spatial and temporal heterogeneity of GBM, the disease prognosis could be significantly improved by a combination of therapeutic strategies in the era of precision medicine.
View Figures
View References

Related Articles

Journal Cover

September-2024
Volume 28 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ius T, Somma T, Pasqualetti F, Berardinelli J, Vitulli F, Caccese M, Cella E, Cenciarelli C, Pozzoli G, Sconocchia G, Sconocchia G, et al: Local therapy in glioma: An evolving paradigm from history to horizons (Review). Oncol Lett 28: 440, 2024.
APA
Ius, T., Somma, T., Pasqualetti, F., Berardinelli, J., Vitulli, F., Caccese, M. ... Lombardi, G. (2024). Local therapy in glioma: An evolving paradigm from history to horizons (Review). Oncology Letters, 28, 440. https://doi.org/10.3892/ol.2024.14573
MLA
Ius, T., Somma, T., Pasqualetti, F., Berardinelli, J., Vitulli, F., Caccese, M., Cella, E., Cenciarelli, C., Pozzoli, G., Sconocchia, G., Zeppieri, M., Gerardo, C., Caffo, M., Lombardi, G."Local therapy in glioma: An evolving paradigm from history to horizons (Review)". Oncology Letters 28.3 (2024): 440.
Chicago
Ius, T., Somma, T., Pasqualetti, F., Berardinelli, J., Vitulli, F., Caccese, M., Cella, E., Cenciarelli, C., Pozzoli, G., Sconocchia, G., Zeppieri, M., Gerardo, C., Caffo, M., Lombardi, G."Local therapy in glioma: An evolving paradigm from history to horizons (Review)". Oncology Letters 28, no. 3 (2024): 440. https://doi.org/10.3892/ol.2024.14573